Press release
Parainfluenza Virus Infection Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | AlloVir, Ansun Biopharma, Moderna Therapeutics
Parainfluenza Virus Infection Pipeline Analysis
DelveInsight reports that over five key companies are actively engaged in developing more than five treatment therapies for Parainfluenza Virus Infection.
Parainfluenza Virus Infection Overview:
The human parainfluenza virus (HPIV) is a single-stranded, negative-sense RNA virus with an envelope, belonging to the Paramyxoviridae family. It is known to cause infections in both the upper and lower respiratory tracts, particularly in young children under five, the elderly, and individuals with weakened immune systems. Although HPIV shares some characteristics with the influenza virus, it is a separate virus and can be clearly distinguished from myxoviruses. Both viruses, however, possess a few antigenic sites and show limited replication in embryonated eggs.
HPIV pathogenesis is shaped by both the host's immune defense and viral actions. The virus initiates infection by binding to host cells using its surface proteins-hemagglutinin-neuraminidase (HN) and fusion (F) glycoproteins-which attach to sialic acid on epithelial cells. Actin and the cytoskeleton play a role in the transcription, maturation, and transportation of viral glycoproteins to the host cell surface.
Request for a detailed insights report on Parainfluenza Virus Infection pipeline insights @ https://www.delveinsight.com/report-store/parainfluenza-virus-infection-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr
"Parainfluenza Virus Infection Pipeline Insight 2025" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Parainfluenza Virus Infection Therapeutics Market.
Key Takeaways from the Parainfluenza Virus Infection Pipeline Report
*
DelveInsight's Parainfluenza Virus Infection pipeline report highlights a dynamic and evolving landscape, with over five active companies developing more than five therapies targeting Parainfluenza Virus Infection. Key players such as AlloVir, Ansun Biopharma, and Moderna Therapeutics are actively advancing drug candidates to enhance treatment options.
*
Among the promising pipeline therapies are candidates like Oplunofusp, which are currently at different stages of clinical development.
*
In November 2025, Blue Lake Biotechnology, Inc., a clinical-stage biotech company specializing in intranasal vaccines using parainfluenza virus 5 (PIV5)-based vectors, along with its affiliate CyanVac LLC, shared positive findings from a Phase 2a trial involving 227 subjects. The study demonstrated the safety, tolerability, immunogenicity, and efficacy of CVXGA, their intranasal COVID-19 vaccine candidate.
*
Additionally, in October 2023, Griffith University partnered with China Grand Pharma to co-develop a novel therapeutic targeting human parainfluenza virus (hPIV). This collaboration seeks to meet the significant unmet need for effective treatments, particularly in high-risk groups such as infants, the elderly, and immunocompromised individuals.
Parainfluenza Virus Infection Pipeline Analysis
The report provides insights into:
*
The report provides detailed insights into the key companies that are developing therapies in the Parainfluenza Virus Infection Market.
*
The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Parainfluenza Virus Infection treatment.
*
It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
*
It navigates the emerging drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
*
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Parainfluenza Virus Infection market.
Download our free sample page report on Parainfluenza Virus Infection pipeline insights [https://www.delveinsight.com/sample-request/parainfluenza-virus-infection-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Parainfluenza Virus Infection Emerging Drugs
*
Oplunofusp: Ansun Biopharma
Parainfluenza Virus Infection Companies
More than five major companies are actively engaged in developing treatments for Parainfluenza Virus Infection. Among these, Ansun Biopharma stands out with a drug candidate that has reached the most advanced stage of development-Phase III.
DelveInsight's report covers around 5+ products under different phases of clinical development like
*
Late stage products (Phase III)
*
Mid-stage products (Phase II)
*
Early-stage product (Phase I) along with the details of
*
Pre-clinical and Discovery stage candidates
*
Discontinued & Inactive candidates
Parainfluenza Virus Infection pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
*
Intravenous
*
Subcutaneous
*
Oral
*
Intramuscular
Parainfluenza Virus Infection Products have been categorized under various Molecule types such as
*
Monoclonal antibody
*
Small molecule
*
Peptide
Download Sample Pages to Get an in-depth Assessment of the Emerging Parainfluenza Virus Infection Therapies and Key Companies: Parainfluenza Virus Infection Clinical Trials and advancements [https://www.delveinsight.com/report-store/parainfluenza-virus-infection-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Parainfluenza Virus Infection Pipeline Therapeutic Assessment
- Parainfluenza Virus Infection Assessment by Product Type
- Parainfluenza Virus Infection By Stage
- Parainfluenza Virus Infection Assessment by Route of Administration
- Parainfluenza Virus Infection Assessment by Molecule Type
Download Parainfluenza Virus Infection Sample report to know in detail about the Parainfluenza Virus Infection treatment market @ Parainfluenza Virus Infection Therapeutic Assessment [https://www.delveinsight.com/sample-request/parainfluenza-virus-infection-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Table of Content
1. Report Introduction
2. Executive Summary
3. Parainfluenza Virus Infection Current Treatment Patterns
4. Parainfluenza Virus Infection - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Parainfluenza Virus Infection Late-Stage Products (Phase-III)
7. Parainfluenza Virus Infection Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Parainfluenza Virus Infection Discontinued Products
13. Parainfluenza Virus Infection Product Profiles
14. Parainfluenza Virus Infection Key Companies
15. Parainfluenza Virus Infection Key Products
16. Dormant and Discontinued Products
17. Parainfluenza Virus Infection Unmet Needs
18. Parainfluenza Virus Infection Future Perspectives
19. Parainfluenza Virus Infection Analyst Review
20. Appendix
21. Report Methodology
Request the Sample PDF to Get Detailed Insights About the Parainfluenza Virus Infection Pipeline Reports Offerings [https://www.delveinsight.com/report-store/parainfluenza-virus-infection-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=parainfluenza-virus-infection-clinical-trials-companies-therapeutic-assessment-therapies-treatment-algorithm-pipeline-analysis-allovir-ansun-biopharma-moderna-therapeutics]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Parainfluenza Virus Infection Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | AlloVir, Ansun Biopharma, Moderna Therapeutics here
News-ID: 4136013 • Views: …
More Releases from ABNewswire
Seborrhea Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatme …
DelveInsight's, "Seborrhea - Pipeline Insight, 2025," report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in the Seborrhea pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
DelveInsight reports that over three key companies are actively engaged in…
Influenza A Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treat …
Influenza A Infections Pipeline Insight, 2025" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Influenza A Infections market. A detailed picture of the Influenza A Infections pipeline landscape is provided, which includes the disease overview and Influenza A Infections treatment guidelines.
DelveInsight reports that several key companies are actively engaged in the ongoing development of treatment therapies for Influenza A.
Influenza A Overview:
The flu…
CRBSI Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment A …
DelveInsight's, "Catheter-related Bloodstream Infection -Pipeline Insight, 2025," report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Catheter-related Bloodstream Infection pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
DelveInsight reports that over five key companies are actively…
Stephen King Joins Benjamin Percy's Serial Novel 'The End Times' as Contributing …
BROOKINGS, SD - Bad Hand Books [https://badhandbooks.com/], an independent publisher of genre fiction based in South Dakota, is thrilled to announce that legendary horror author Stephen King has joined us as a contributing writer for Benjamin Percy's The End Times [https://badhandbooks.com/preorders/the-end-times-digital-subscription]. The short, serialized novel will begin publishing in November as a monthly newspaper in physical and digital formats.
"The end of human civilization just got a lot cooler," said Doug…
More Releases for Parainfluenza
Parainfluenza virus infection Market: Epidemiology, Therapies, Companies, DelveI …
Parainfluenza virus infection therapies, such as DAS181, ALVR106, and others, are expected to boost the Parainfluenza virus infection Market in the upcoming years.
DelveInsight has launched a new report on "Parainfluenza virus infection - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Parainfluenza virus infection, historical and forecasted epidemiology as well as the Parainfluenza virus infection market trends in the United States, EU5 (Germany, Spain, Italy,…
Parainfluenza Virus Infection Market to Expand Significantly by 2034, States Del …
The Key Parainfluenza Virus Infection Companies in the market include - Ansun Biopharma, AlloVir, MedImmune LLC, and others.
DelveInsight's "Parainfluenza Virus Infection Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Parainfluenza Virus Infection, historical and forecasted epidemiology as well as the Parainfluenza Virus Infection market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an…
Parainfluenza Virus Infection-Market Outlook report Assessment, Growth Trends, E …
It has been observed that, the global market for Parainfluenza Virus Infection-Market would be experiencing steady growth marked in million US$ by 2025. Such advancements can be attributed to the efforts put in by prime manufacturers operating in the global Parainfluenza Virus Infection-Market during the period 2028. All such statistics and figures are carefully enclosed in a recently uploaded research report titled “Parainfluenza Virus Infection-Market Insights, Epidemiology and Market” Forecast-2028,…
What's driving the Human Parainfluenza Viruses Diagnostics Market Size ? Qiagen, …
Market Study Report recently added a new report on Global Human Parainfluenza Viruses Diagnostics Market, which is an in-depth study providing complete analysis of the industry for the period 2018 to 2023. It provides complete overview of Global Human Parainfluenza Viruses Diagnostics industry considering all the major industry trends, market dynamics and competitive scenario.
The Human Parainfluenza Viruses Diagnostics market research report provides an in-depth analysis of the business space in…
Driving Innovation: Human Parainfluenza Viruses Diagnostics Market By Key Player …
Qyresearchreports include new market research report Human Parainfluenza Viruses Diagnostics to its huge collection of research reports.
Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers and known as carcinogenic HPVs.
The human…
Human Parainfluenza Viruses Diagnostics Market will reach 940 million USD in 202 …
New report published by Global Info Research which offers insights on the global Human Parainfluenza Viruses Diagnostics market.
Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers and known as carcinogenic HPVs.
Click…
